- Investopedia•44 minutes ago
Merck’s antiviral drug letermovir posted positive results in a late-stage trial.
- Market Realist•50 minutes ago
In 4Q16, Effient's US sales saw a $12 million increase, and its international sales saw a $11 million decrease.
- Market Realist•52 minutes ago
Out of the 21 analysts covering Merck & Co., 62% of analysts recommended a “buy,” ~33% of analysts recommended a “hold,” and 5% of analysts recommended a “sell” on February 20, 2017.
MRK : Summary for Merck & Company, Inc. Common St - Yahoo Finance
Merck & Co., Inc. (MRK)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||65.63 - 66.11|
|52 Week Range||50.09 - 66.11|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.32|
|Dividend & Yield||1.88 (2.88%)|
|1y Target Est||N/A|